Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dialysis patients get stronger and sleep better with In-Chair exercise program

NCT ID NCT07447375

Symptom relief Sponsor: University of Salamanca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 12-week supervised exercise program done during dialysis can improve muscle mass, strength, sleep, and quality of life in adults over 40 with chronic kidney disease. Participants are randomly assigned to either exercise during the first 90 minutes of dialysis or receive standard care. The goal is to see if adding exercise to routine care helps reduce sarcopenia (muscle loss) and improve overall well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects currently enrolled in a Chronic Hemodialysis Unit. * Patients who have been on hemodialysis treatment for more than 3 months. * Subjects aged 40 years or older. * Hemoglobin levels greater than 10 mg/dl. * Ability to perform physical fitness assessment tests or dynamometry. * Willingness and ability to provide signed informed consent Exclusion Criteria: * Presence of intradialytic instability. * Medical conditions where exercise is contraindicated: active infectious process, neoplasms, uncontrolled arrhythmias, or left ventricular dysfunction (EF \< 35%). * Musculoskeletal or respiratory alterations that worsen with exercise. * Lower limb amputation without a prosthesis. * Cerebrovascular disease (stroke with sequelae or transient ischemic attacks within the previous 6 weeks). * Uncontrolled hypertension (Systolic BP \> 200 mmHg or Diastolic BP \> 120 mmHg). * Unstable angina (at rest or during exercise) or history of coronary bypass/ischemic heart disease within the previous 6 weeks. * Diabetes mellitus with severe decompensation (blood glucose \> 300 mg/dl). * Dialysis-related hypotension (mean blood pressure \< 90/70 mmHg). * Psychiatric or cognitive alterations that prevent collaboration with muscle training programs. * Presence of an arteriovenous fistula in a lower limb. * Motor neurological injury causing dysfunction that prevents the application of the strength protocol. * Hospitalization within the 3 months prior to the study. * Lack of cooperation (defined as failing to attend more than 25% of sessions) or inability to understand the treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Renal insufficiency, chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome insomnia Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Renal insufficiency, chronic Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universidad de Salamanca

    RECRUITING

    Salamanca, Salamanca, 37008, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.